Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
Phase 2
Recruiting
- Conditions
- Prostate Cancer (Adenocarcinoma)Prostate CAProstate CancersProstate Cancer (Post Prostatectomy)Prostate CancerProstate Cancer Patients Undergoing Radical ProstatectomyHigh-risk Prostate Cancer
- Interventions
- Biological: Standard of Care (SOC)
- First Posted Date
- 2024-10-15
- Last Posted Date
- 2024-10-21
- Lead Sponsor
- Cellvax Therapeutics Inc
- Target Recruit Count
- 100
- Registration Number
- NCT06636682
- Locations
- 🇺🇸
Carolina Urologic Research Center, Myrtle Beach, South Carolina, United States
🇺🇸University of Chicago Medicine, High-Risk and Advanced Prostate Cancer Clinic, Chicago, Illinois, United States
🇺🇸Central Ohio Urology Group, Gahanna, Ohio, United States
News
No news found